Some ingestible cannabis products that Health Canada considers noncompliant with federal rules still appear to be widely available in parts of the country, almost a year after the regulator asked companies to stop selling them to consumers because of concerns about overconsumption of THC.
The Ontario government is proposing a number of significant legislative and regulatory changes to its cannabis framework that it says would combat the illegal market.
Canada’s federal health regulator has approved Jazz Pharmaceuticals Canada’s cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain rare and severe forms of epilepsy, allowing the company to bring to market a clinically tested drug with global sales that dwarf those of the nation’s entire medical cannabis industry
Canadian marijuana producer SNDL and retailer Nova Cannabis have mutually agreed to terminate the agreement they announced late last year to implement a strategic partnership.
Canadian cannabis producer Canopy Growth said an Ontario court has greenlit the sale of its BioSteel Canada subsidiary and U.S. affiliate, BioSteel Manufacturing, in two separate deals.
Federally licensed cannabis producers in British Columbia are eligible to apply for a host of government programs, some of which provide funding, including the provincial portion of the Sustainable Canadian Agricultural Partnership.
Canadian cannabis producer Canopy Growth Corp. appears to be facing another hurdle in its plan to “fast track” the company’s entry into the $34 billion U.S. marijuana market.
A vote on Germany’s watered-down bill to legalize some recreational cannabis use has been delayed until at least December.
A draft law in Japan to legalize some pharmaceutically derived medical cannabinoid medicines, while bolstering criminal penalties for marijuana use, has been approved by the country’s House of Representatives.
One after another, many of Canada’s largest cannabis greenhouses and indoor grow operations have been sold or mothballed as the industry continues to search for a supply-demand equilibrium after years of overproduction.
Calgary, Alberta-based cannabis producer Ogen has closed its doors, an executive announced, making the company the latest casualty in Canada’s cutthroat marijuana industry.
Alcohol giant Constellation Brands said all its warrants have expired to purchase common shares of Canadian cannabis producer Canopy Growth Corp. and signaled it has “no other present plans” that relate to Canopy.
